Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
spark therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
amgen
amicus therapeutics
biotech
clinical trials
cystic fibrosis
deals
diagnostics
gene therapy
immunotherapy
medicare
merck
novartis
What
bio
3
×
drug
3
×
patients
3
×
roundup
acquisitions
advantages
albert
aren’t
bar
biggest
bourla
brings
ceo
company
crispr
developers
drugs
expect
fda
future
gamble
gene
help
imminent
imports
long
maker
maps
market
measured
medco’s
medicare
mover
moves
new
news
noteworthy
payers
pfizer
pfizer’s
Language
unknown
unset
Current search:
bio
×
drug
×
patients
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More